Immunotherapy in Urothelial Cancer, Part 2: Adjuvant, Neoadjuvant, and Adjunctive Treatment

  Abstract:  Urothelial cancer, which is predominantly seen in men, is common throughout the world. Most disease presents as non–muscle invasive bladder cancer (NMIBC), with cancer […]

Immunotherapy in Urothelial Cancer, Part 1: T-Cell Checkpoint Inhibition in Advanced or Metastatic Disease

  Abstract: Cancer of the urothelium is the sixth most common cancer in the United States and is seen predominantly in men. Most cases of this […]

New Treatments for Bladder Cancer

H&O  How common is bladder cancer? NH  Bladder cancer is very common in the United States; it is the fifth most common cancer diagnosed in this […]

Bladder Cancer: Advances in Treatment and Research

H&O  What is the background on bladder cancer and the current state of this disease? MG  Bladder cancer affects approximately 70,000 patients a year in the United States […]